PubMed Health⌕ Search

Biomedical subjects

J Cort

Publications and source records attributed to J Cort.

10 recordsLinked to original sources

Anaesthesia for cardioversion: a comparison of sevoflurane and propofol.

This study compared the induction time, haemodynamic changes, recovery characteristics and patient satisfaction for sevoflurane and propofol when used as the main anaesthetic agents for cardioversion. Sixty-one unpremedicated patients scheduled for elective cardioversion were anaesthetised with either inhaled sevoflurane 8% or an intravenous propofol target-controlled infusion set at 6 microg.ml(-1). There was no significant difference in induction time between the two groups: mean (SD) = 90.1(40) s in the sevoflurane group vs. 83.7(35) s in the propofol group. Mean (SD) time to recovery was significantly shorter in the sevoflurane group than in the propofol group: 318 (127) s vs.738 (355) s, respectively, p < 0.001. At recovery, the patients in the propofol group had significantly lower systolic and diastolic blood pressures than those in the sevoflurane group, p < 0.001. The incidence of complications was low in both groups, with similar patient satisfaction expressed after the procedure. We conclude that sevoflurane is a suitable choice for anaesthesia for cardioversion and may provide greater haemodynamic stability than a target-controlled infusion of propofol.

Adult↗

Beta-structure in human amylin and two designer beta-peptides: CD and NMR spectroscopic comparisons suggest soluble beta-oligomers and the absence of significant populations of beta-strand dimers.

Intensity variation for the positive far UV CD band was observed for three 'beta-sheet' peptides. In 6% HFIP, an amyloidogenic species (human pancreatic amylin) displays, on standing, an extremely intense 192-nm band which diminishes upon physical agitation. A concurrently formed Tyr sidechain band at 274 nm disappears completely with agitation, linking the enhancement of the 192-nm band to the highly ordered stacking of beta-sheets. NMR studies indicate that the beta-states of the three peptides are oligomeric, not beta dimers. A membrane-forming EAK peptide displays NMR peaks due to the low concentration of 'random coil' monomers present in slow equilibrium with beta-oligomers; solutions of a more hydrophobic ELKA peptide, which displays an intense 195-nm band, contain only oligomeric species. NMR studies at 25% HFIP revealed the structural requirements for inhibition of beta-oligomer formation.

Amino Acid Sequence↗

A decade of nuclear pacing.

In April, 1973, a decade-long study was begun on nuclear-powered pacemakers. The first 15 of these were designed by the Numec Corporation under a contract from the United States Atomic Energy Commission. Altogether 151 units powered by the isotope plutonium 238 were implanted in 131 patients; the pacemakers of 4 different manufacturers were used. The last nuclear pacemaker was implanted in January, 1983. The actuarial survival at 10 years was 92%, meeting the original performance goal of the Commission of 90%. Ninety pulse generators are still in service today; 25 patients have died and 36 pulse generators have been replaced with non-nuclear units. The most common indication for replacement was an inappropriate pacing mode. This high reliability and superior performance suggest that continued use of a radioisotopic power source is justified, particularly if combined with the electronic circuits of today's dual-chambered, multiprogrammable, and multifunctional pacemakers.

Equipment Design↗